Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target
- 1 October 2009
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 16 (4), 309-323
- https://doi.org/10.1016/j.ccr.2009.08.019
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase–dependent mechanismJCI Insight, 2008
- Improved survival in multiple myeloma and the impact of novel therapiesBlood, 2008
- Recent major improvement in long-term survival of younger patients with multiple myelomaBlood, 2008
- Plasmacytoid dendritic cells induce NK cell–dependent, tumor antigen–specific T cell cross-priming and tumor regression in miceJCI Insight, 2008
- TLR9 and DNA 'feel' RAGENature Immunology, 2007
- Synopsis of a Roundtable on Validating Novel Therapeutics for Multiple MyelomaClinical Cancer Research, 2006
- Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patientsBlood, 2006
- Enhancement of clonogenicity of human multiple myeloma by dendritic cellsThe Journal of Experimental Medicine, 2006
- Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasmsLaboratory Investigation, 2006
- Dendritic cells associated with plasmablast survivalEuropean Journal of Immunology, 1999